{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:13Z","timestamp":1791895513323,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Tianshan Talent Training Program","award":["2022TSYCLJ0028"],"award-info":[{"award-number":["2022TSYCLJ0028"]}]},{"name":"The Xinjiang Uygur Autonomous Region key research and development project","award":["2022B03022-2"],"award-info":[{"award-number":["2022B03022-2"]}]},{"name":"The Special Fund Project for Central Guidance of Local Science and Technology Development","award":["ZYYD2022C21"],"award-info":[{"award-number":["ZYYD2022C21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Atherosclerosis and metabolic syndrome are the main causes of cardiovascular events, but their underlying mechanisms are not clear. In this study, we focused on identifying genes associated with diagnostic biomarkers and effective therapeutic targets associated with these two diseases.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Transcriptional data sets of atherosclerosis and metabolic syndrome were obtained from GEO database. The differentially expressed genes were analyzed by RStudio software, and the function-rich and protein-protein interactions of the common differentially expressed genes were analyzed.Furthermore, the hub gene was screened by Cytoscape software, and the immune infiltration of hub gens was analyzed. Finally, relevant clinical blood samples were collected for qRT-PCR verification of the three most important hub genes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 1242 differential genes (778 up-regulated genes and 464 down-regulated genes) were screened from GSE28829 data set. A total of 1021 differential genes (492 up-regulated genes and 529 down-regulated genes) were screened from the data set GSE98895. Then 23 up-regulated genes and 11 down-regulated genes were screened by venn diagram. Functional enrichment analysis showed that cytokines and immune activation were involved in the occurrence and development of these two diseases. Through the construction of the Protein\u2013Protein Interaction(PPI) network and Cytoscape software analysis, we finally screened 10 hub genes. The immune infiltration analysis was further improved. The results showed that the infiltration scores of 7 kinds of immune cells in GSE28829 were significantly different among groups (Wilcoxon Test\u2009<\u20090.05), while in GSE98895, the infiltration scores of 4 kinds of immune cells were significantly different between groups (Wilcoxon Test\u2009<\u20090.05). Spearman method was used to analyze the correlation between the expression of 10 key genes and 22 kinds of immune cell infiltration scores in two data sets. The results showed that there were 42 pairs of significant correlations between 10 genes and 22 kinds of immune cells in GSE28829 (|Cor| > 0.3 &\n P<\/jats:italic>\n \u2009<\u20090.05). There were 41 pairs of significant correlations between 10 genes and 22 kinds of immune cells in GSE98895 (|Cor| > 0.3 &\n P<\/jats:italic>\n \u2009<\u20090.05). Finally, our results identified 10 small molecules with the highest absolute enrichment value, and the three most significant key genes (\n CX3CR1<\/jats:italic>\n ,\n TLR5<\/jats:italic>\n ,\n IL32<\/jats:italic>\n ) were further verified in the data expression matrix and clinical blood samples.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n We have established a co-expression network between atherosclerotic progression and metabolic syndrome, and identified key genes between the two diseases. Through the method of bioinformatics, we finally obtained 10 hub genes in As and MS, and selected 3 of the most significant genes (\n CX3CR1<\/jats:italic>\n ,\n IL32<\/jats:italic>\n ,\n TLR5<\/jats:italic>\n ) for blood PCR verification. This may be helpful to provide new research ideas for the diagnosis and treatment of AS complicated with MS.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s12872-024-04026-3","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T01:02:22Z","timestamp":1722560542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification and verification of immune-related genes for diagnosing the progression of atherosclerosis and metabolic syndrome"],"prefix":"10.1186","volume":"24","author":[{"given":"Qian","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"5","key":"4026_CR1","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","volume":"8","author":"P Song","year":"2020","unstructured":"Song P, Fang Z, Wang H, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study [J]. Lancet Glob Health. 2020;8(5):e721\u20139.","journal-title":"Lancet Glob Health"},{"issue":"29","key":"4026_CR2","doi-asserted-by":"publisher","first-page":"e2110660","DOI":"10.1002\/adma.202110660","volume":"34","author":"S Zhang","year":"2022","unstructured":"Zhang S, Liu Y, Cao Y, et al. Targeting the Microenvironment of Vulnerable atherosclerotic plaques: an emerging diagnosis and therapy strategy for atherosclerosis [J]. Adv Mater. 2022;34(29):e2110660.","journal-title":"Adv Mater"},{"key":"4026_CR3","doi-asserted-by":"crossref","unstructured":"Kovanen PT. Mast cells as potential accelerators of human atherosclerosis-from early to late lesions [J]. Int J Mol Sci, 2019, 20(18).","DOI":"10.3390\/ijms20184479"},{"issue":"31","key":"4026_CR4","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/eurheartj\/ehaa227","volume":"41","author":"M Tomaniak","year":"2020","unstructured":"Tomaniak M, Katagiri Y, Modolo R, et al. Vulnerable plaques and patients: state-of-the-art [J]. Eur Heart J. 2020;41(31):2997\u20133004.","journal-title":"Eur Heart J"},{"issue":"3","key":"4026_CR5","doi-asserted-by":"publisher","first-page":"e3502","DOI":"10.1002\/dmrr.3502","volume":"38","author":"JL Silveira Rossi","year":"2022","unstructured":"Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, et al. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors [J]. Diabetes Metab Res Rev. 2022;38(3):e3502.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"4026_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/met.2019.0073","volume":"18","author":"R Parsanathan","year":"2020","unstructured":"Parsanathan R, Jain SK. Novel invasive and noninvasive cardiac-specific biomarkers in obesity and Cardiovascular diseases [J]. Metab Syndr Relat Disord. 2020;18(1):10\u201330.","journal-title":"Metab Syndr Relat Disord"},{"key":"4026_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2147\/JIR.S393788","volume":"16","author":"Y Fu","year":"2023","unstructured":"Fu Y, Xu L, Zhang H, et al. Identification and validation of Immune-related genes diagnostic for progression of atherosclerosis and diabetes [J]. J Inflamm Res. 2023;16:505\u201321.","journal-title":"J Inflamm Res"},{"key":"4026_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0076-6879(06)11008-3","volume":"411","author":"M Reimers","year":"2006","unstructured":"Reimers M, Carey VJ. Bioconductor: an open source framework for bioinformatics and computational biology [J]. Methods Enzymol. 2006;411:119\u201334.","journal-title":"Methods Enzymol"},{"issue":"D1","key":"4026_CR9","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"Expansion of the Gene Ontology knowledgebase and resources [J]","year":"2017","unstructured":"Expansion of the Gene Ontology knowledgebase and resources [J]. Nucleic Acids Res. 2017;45(D1):D331\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4026_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes [J]. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"4026_CR11","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1073\/pnas.1603992113","volume":"113","author":"A Vinayagam","year":"2016","unstructured":"Vinayagam A, Gibson TE, Lee HJ, et al. Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets [J]. Proc Natl Acad Sci U S A. 2016;113(18):4976\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4026_CR12","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1038\/s41598-018-23672-0","volume":"8","author":"D Vella","year":"2018","unstructured":"Vella D, Marini S, Vitali F, et al. MTGO: PPI Network Analysis Via Topological and Functional Module Identification [J]. Sci Rep. 2018;8(1):5499.","journal-title":"Sci Rep"},{"key":"4026_CR13","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, et al. IOBR: Multi-omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and signatures [J]. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"issue":"19","key":"4026_CR14","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J]. JAMA. 2001;285(19):2486\u201397.","journal-title":"JAMA"},{"issue":"1","key":"4026_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, et al. Atherosclerosis [J]. Nat Rev Dis Primers. 2019;5(1):56.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"4026_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","volume":"28","author":"SM Grundy","year":"2008","unstructured":"Grundy SM. Metabolic syndrome pandemic [J]. Arterioscler Thromb Vasc Biol. 2008;28(4):629\u201336.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4026_CR17","doi-asserted-by":"crossref","unstructured":"Grundy SM, Brewer HB Jr., Cleeman JI et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition [J]. Circulation, 2004, 109(3): 433-8.","DOI":"10.1161\/01.CIR.0000111245.75752.C6"},{"issue":"7121","key":"4026_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes [J]. Nature. 2006;444(7121):840\u20136.","journal-title":"Nature"},{"issue":"2","key":"4026_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2337\/diacare.16.2.434","volume":"16","author":"J Stamler","year":"1993","unstructured":"Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial [J]. Diabetes Care. 1993;16(2):434\u201344.","journal-title":"Diabetes Care"},{"issue":"4","key":"4026_CR20","first-page":"282","volume":"18","author":"G Steiner","year":"1995","unstructured":"Steiner G. Dyslipoproteinemias in diabetes [J]. Clin Invest Med. 1995;18(4):282\u20137.","journal-title":"Clin Invest Med"},{"issue":"9","key":"4026_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.4330\/wjc.v6.i9.890","volume":"6","author":"G Mul\u00e8","year":"2014","unstructured":"Mul\u00e8 G, Calcaterra I, Nardi E, et al. Metabolic syndrome in hypertensive patients: an unholy alliance [J]. World J Cardiol. 2014;6(9):890\u2013907.","journal-title":"World J Cardiol"},{"issue":"4","key":"4026_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0749-0690(18)30649-9","volume":"5","author":"M Carethers","year":"1989","unstructured":"Carethers M, Blanchette PL. Pathophysiology of hypertension [J]. Clin Geriatr Med. 1989;5(4):657\u201374.","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"4026_CR23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S1521-6918(04)00091-5","volume":"18","author":"X Formiguera","year":"2004","unstructured":"Formiguera X, Cant\u00f3n A. Obesity: epidemiology and clinical aspects [J]. Best Pract Res Clin Gastroenterol. 2004;18(6):1125\u201346.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7121","key":"4026_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease [J]. Nature. 2006;444(7121):875\u201380.","journal-title":"Nature"},{"key":"4026_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2458-9-88","volume":"9","author":"DP Guh","year":"2009","unstructured":"Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis [J]. BMC Public Health. 2009;9:88.","journal-title":"BMC Public Health"},{"issue":"4","key":"4026_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1017\/S0029665113002048","volume":"72","author":"CM Williams","year":"2013","unstructured":"Williams CM, Lovegrove JA, Griffin BA. Dietary patterns and cardiovascular disease [J]. Proc Nutr Soc. 2013;72(4):407\u201311.","journal-title":"Proc Nutr Soc"},{"issue":"9497","key":"4026_CR27","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","volume":"366","author":"S Yusuf","year":"2005","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study [J]. Lancet. 2005;366(9497):1640\u20139.","journal-title":"Lancet"},{"issue":"7","key":"4026_CR28","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/eurheartj\/ehm026","volume":"28","author":"L de Koning","year":"2007","unstructured":"de Koning L, Merchant AT, Pogue J, et al. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies [J]. Eur Heart J. 2007;28(7):850\u20136.","journal-title":"Eur Heart J"},{"issue":"9669","key":"4026_CR29","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"G Whitlock","year":"2009","unstructured":"Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies [J]. Lancet. 2009;373(9669):1083\u201396.","journal-title":"Lancet"},{"issue":"Suppl A","key":"4026_CR30","first-page":"a3","volume":"16","author":"J Jr Genest","year":"2000","unstructured":"Jr. Genest J J G. Dyslipidemia and coronary artery disease. Can J Cardiol. 2000;16(Suppl A):a3\u20134.","journal-title":"Can J Cardiol"},{"issue":"1","key":"4026_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.CIR.0000108926.04022.0C","volume":"109","author":"JK Ninomiya","year":"2004","unstructured":"Ninomiya JK, L\u2019Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey [J]. Circulation. 2004;109(1):42\u20136.","journal-title":"Circulation"},{"issue":"4","key":"4026_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","volume":"91","author":"T Imai","year":"1997","unstructured":"Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion [J]. Cell. 1997;91(4):521\u201330.","journal-title":"Cell"},{"issue":"7","key":"4026_CR33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1161\/01.CIR.0000057548.68243.42","volume":"107","author":"C Combadi\u00e8re","year":"2003","unstructured":"Combadi\u00e8re C, Potteaux S, Gao JL, et al. Decreased atherosclerotic lesion formation in CX3CR1\/apolipoprotein E double knockout mice [J]. Circulation. 2003;107(7):1009\u201316.","journal-title":"Circulation"},{"issue":"3","key":"4026_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1172\/JCI15555","volume":"111","author":"P Lesnik","year":"2003","unstructured":"Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1-\/- mice reveals a role for fractalkine in atherogenesis [J]. J Clin Invest. 2003;111(3):333\u201340.","journal-title":"J Clin Invest"},{"issue":"10","key":"4026_CR35","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1073\/pnas.0813334106","volume":"106","author":"CA Nold-Petry","year":"2009","unstructured":"Nold-Petry CA, Nold MF, Zepp JA, et al. IL-32-dependent effects of IL-1beta on endothelial cell functions [J]. Proc Natl Acad Sci U S A. 2009;106(10):3883\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4026_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cyto.2013.05.002","volume":"64","author":"B Heinhuis","year":"2013","unstructured":"Heinhuis B, Popa CD, van Tits BL, et al. Towards a role of interleukin-32 in atherosclerosis [J]. Cytokine. 2013;64(1):433\u201340.","journal-title":"Cytokine"},{"key":"4026_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.0105-2896.2005.00239.x","volume":"204","author":"IR Rifkin","year":"2005","unstructured":"Rifkin IR, Leadbetter EA, Busconi L, et al. Toll-like receptors, endogenous ligands, and systemic autoimmune disease [J]. Immunol Rev. 2005;204:27\u201342.","journal-title":"Immunol Rev"},{"key":"4026_CR38","doi-asserted-by":"publisher","first-page":"42688","DOI":"10.1038\/srep42688","volume":"7","author":"GH Ellenbroek","year":"2017","unstructured":"Ellenbroek GH, van Puijvelde GH, Anas AA, et al. Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness [J]. Sci Rep. 2017;7:42688.","journal-title":"Sci Rep"},{"key":"4026_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopha.2016.04.031","volume":"81","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang Y. Pterostilbene, a novel natural plant conduct, inhibits high fat-induced atherosclerosis inflammation via NF-\u03baB signaling pathway in toll-like receptor 5 (TLR5) deficient mice [J]. Biomed Pharmacother. 2016;81:345\u201355.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4026_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","volume":"168","author":"KA Zarember","year":"2002","unstructured":"Zarember KA, Godowski PJ. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines [J]. J Immunol. 2002;168(2):554\u201361.","journal-title":"J Immunol"},{"issue":"2","key":"4026_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2013.02.028","volume":"228","author":"JA van Diepen","year":"2013","unstructured":"van Diepen JA, Berb\u00e9e JF, Havekes LM, et al. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis [J]. Atherosclerosis. 2013;228(2):306\u201315.","journal-title":"Atherosclerosis"},{"issue":"SupplSuppl","key":"4026_CR42","doi-asserted-by":"publisher","first-page":"S376","DOI":"10.1194\/jlr.R800087-JLR200","volume":"50","author":"D Steinberg","year":"2009","unstructured":"Steinberg D. The LDL modification hypothesis of atherogenesis: an update [J]. J Lipid Res. 2009;50(SupplSuppl):S376\u201381.","journal-title":"J Lipid Res"},{"issue":"5","key":"4026_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.arcmed.2015.06.004","volume":"46","author":"V Garc\u00eda-Gonz\u00e1lez","year":"2015","unstructured":"Garc\u00eda-Gonz\u00e1lez V, Delgado-Coello B, P\u00e9rez-Torres A, et al. Reality of a vaccine in the Prevention and Treatment of atherosclerosis [J]. Arch Med Res. 2015;46(5):427\u201337.","journal-title":"Arch Med Res"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04026-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T01:02:41Z","timestamp":1722560561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04026-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4026"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04026-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3981358\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the First Affiliated Hospital of Xinjiang Medical University (20220308-105). All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}